|
WO2019246119A1
|
|
Antibiotics for veterinary staphylococcal infections
|
|
EP3600295A1
|
|
Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors
|
|
US2018133282A1
|
|
Method of treating low blood pressure
|
|
US2018015207A1
|
|
Smart release system for growth factor delivery and combined bone and vascular growth
|
|
US2019030056A1
|
|
Methods and compounds for treating malaria
|
|
US2019033297A1
|
|
Compounds inhibiting Nef-calnexin interaction
|
|
US2020237963A1
|
|
Biocompatible smart biomaterials with tunable shape changing and enhanced cytocompatibility properties
|
|
US2018263935A1
|
|
Treatment for mitochondrial diseases
|
|
US2017369946A1
|
|
Blood biomarkers for respiratory infections
|
|
US2018135127A1
|
|
Blood biomarkers for appendicitis and diagnostics methods using biomarkers
|
|
US2016228611A1
|
|
Biomimetic biphasic 3D nanocomposite scaffold for osteochondral regeneration
|
|
EP2986308A1
|
|
Angiotensin ii in combination for the treatment of hypotension
|
|
US2016101216A1
|
|
Myocyte-derived flow assist device: extravasal sheaths of rhythmically contracting myocytes aiding flow of biological fluids
|
